Polymer Nanoparticles for Preferential Delivery of Drugs Only by Exploiting the Slightly Elevated Temperature of Cancer Cells and Real-Time Monitoring of Drug Release
Biomacromolecules · 2024
DOI: 10.1021/acs.biomac.4c00572 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomacromolecules, 2024. Verfasst von Juthi Pal und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Nanoparticles, Drug Liberation, Doxorubicin, Polymers. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Science and Engineering Research Board, Indian Institute of Technology Kharagpur, Ministry of Education, India.
Abstract (Originalsprache)
Rapid proliferation and a faster rate of glycolysis in cancer cells often result in an elevated local temperature (40-43 °C) at the tumor site. Nanoparticles prepared from polymers with two lower critical solution temperatures (LCSTs) can be utilized to take advantage of this subtle temperature elevation to deliver anticancer drugs preferably to the cancer cells, thereby enhancing the overall therapeutic efficacy and reducing side effects. In this direction, we synthesized N-vinyl-2-pyrrolidone (NVP) and substituted NVP (sub-NVP: C2-NVP, C4-NVP)-based polymers with precisely controlled LCSTs by varying the ratio of NVP and sub-NVP. The first LCST (LCST1) was kept below 37 °C to promote self-assembly, drug loading, and structural stability in physiological conditions and the second LCST (LCST2) was in the range of 40-43 °C to ensure mild hyperthermia-induced drug release. Additionally, covalent attachment of tetraphenylethylene (TPE, AIEgen) resulted in aggregation-induced emission in thermoresponsive micellar nanoparticles in which TPE acted as a Förster Resonance Energy Transfer (FRET) pair with the loaded anticancer drug doxorubicin (DOX). Tracking of FRET-induced fluorescence recovery of TPE molecules was utilized to confirm the real-time thermoresponsive release of DOX from nanoparticles and eventual localization of TPE in the cytoplasm and DOX in the nucleus. In vitro cellular studies such as cytotoxicity, cellular uptake, and thermoresponsive drug release showed that the DOX-loaded polymeric nanoparticles were nontoxic to normal cells (HEK-293) but significantly more effective in cancer cells (MCF-7) at 40 °C. To our knowledge, this is the first report of preferential delivery of anticancer drugs only by exploiting the slightly elevated temperature of cancer cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
ORCID-Profile: Juthi Pal, Mahitosh Mandal, Dibakar Dhara
Förderung
- Science and Engineering Research Board
- Indian Institute of Technology Kharagpur
- Ministry of Education, India
Zitieren
APA
Pal, J., Kola, P., Samanta, P., Mandal, M., & Dhara, D. (2024). Polymer Nanoparticles for Preferential Delivery of Drugs Only by Exploiting the Slightly Elevated Temperature of Cancer Cells and Real-Time Monitoring of Drug Release. Biomacromolecules. https://doi.org/10.1021/acs.biomac.4c00572
Vancouver
Pal J, Kola P, Samanta P, Mandal M, Dhara D. Polymer Nanoparticles for Preferential Delivery of Drugs Only by Exploiting the Slightly Elevated Temperature of Cancer Cells and Real-Time Monitoring of Drug Release. Biomacromolecules. 2024. doi:10.1021/acs.biomac.4c00572
BibTeX
@article{Pal2024,
author = {Pal, Juthi and Kola, Prithwish and Samanta, Pousali and Mandal, Mahitosh and Dhara, Dibakar},
title = {Polymer Nanoparticles for Preferential Delivery of Drugs Only by Exploiting the Slightly Elevated Temperature of Cancer Cells and Real-Time Monitoring of Drug Release},
journal = {Biomacromolecules},
year = {2024},
doi = {10.1021/acs.biomac.4c00572}
}
EUVIMED